Skip to main content

Advertisement

Log in

Effects of pravastatin in murine collagen-induced arthritis

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Here we evaluated whether 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) have beneficial effects for collagen-induced arthritis (CIA). DBA/1 mice were immunized with bovine type-II collagen and administered 100 mg/kg of pravastatin interperitoneally. We measured the effects of pravastatin for CIA including infiltration of macrophages at the synovial membrane and production of anti-type-II collagen antibodies and cytokines. Adverse reactions of pravastatin were also measured. The pravastatin-treated mice had delayed onset of CIA compared with the controls. The involvement of inflammatory cells in the synovial membrane and the expression of monocyte chemotactic protein-1 (MCP-1) mRNA in the joint were reduced. Moreover, some cytokines (TNF-α, IL-6, IFN-γ) and MCP-1 levels in the supernatants of spleen cells cultured with pravastatin decreased. Meanwhile, adverse reactions of pravastatin, such as peritonitis, were not detected. Pravastatin may have good prospects for treating some anti-inflammatory effects on human rheumatoid arthritis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397–440

    Article  PubMed  CAS  Google Scholar 

  2. Gracie JA, Forsey RJ, Chan WL, Gilmour A, Leung BP, Greer MR, Kennedy K, Carter R, Wei XQ, Xu D, Field M, Foulis A, Liew FY, McInnes IB (1999) A proinflammatory role for IL-18 in rheumatoid arthritis. J Clin Invest 104:1393–1401

    Article  PubMed  CAS  Google Scholar 

  3. Yamamura M, Kawashima M, Taniai M, Yamauchi H, Tanimoto T, Kurimoto M, Morita Y, Ohmoto Y, Makino H (2001) Interferon-γ-inducing activity of interleukin-18 in the joint of rheumatoid arthritis. Arthritis Rheum 44:275–285

    Article  PubMed  CAS  Google Scholar 

  4. Trentham DE, Townes AS, Kang AH (1977) Autoimmunity to type II, collagen: an experimental model of arthritis. J Exp Med 146:857–868

    Article  PubMed  CAS  Google Scholar 

  5. Durie FH, Fava RA, Noelle RJ (1994) Collagen-induced arthritis as a model of rheumatoid arthritis. Clin Immunol Immunopathol 73:11–18

    Article  PubMed  CAS  Google Scholar 

  6. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B (1980) Immunization against heterologous type II collagen induces arthritis in mice. Nature 283:666–668

    Article  PubMed  CAS  Google Scholar 

  7. Stuart JM, Townes AS, Kang AH (1984) Collagen autoimmune arthritis. Ann Rev Immunol 2:199–218

    Article  CAS  Google Scholar 

  8. Inoue I, Goto S, Mizotani K, Awata T, Mastunaga T, Kawai S, Nakajima T, Hokari S, Komada T, Katayama S (2000) Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect Reduction of MRNA levels for interleukin-1β, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor α (PPARα) in primary endothelial cells. Life Sci 67:863–876

    Article  PubMed  CAS  Google Scholar 

  9. Zelvyte I, Dominaitiene R, Crisby M, Janciauskiene S (2002) Modulation of inflammatory mediators and PPARγ and NFκB expression by pravastatin in response to lipoproteins in human monocytes invitro. Pharmacol Res 45:147–154

    Article  PubMed  CAS  Google Scholar 

  10. Romano M, Diomede L, Sironi M, Massimiliano L, Sottocorno M, Polentarutti N, Guglielmotti A, Albani D, Bruno A, Fruscella P, Salmona M, Vecchi A, Pinza M, Mantovani A (2000) Inhibition of monocyte chemotactic protein-1 synthesis by statin. Lab Invest 80:1095–1100

    PubMed  CAS  Google Scholar 

  11. Kwak B, Mulhaupt F, Myit S, Mach F (2000) Statins as a newly recognized type of immunomodulator. Nat Med 6:1399–1402

    Article  PubMed  CAS  Google Scholar 

  12. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, Cottens S, Takada T, Hommel U (2001) Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med 7:687–692

    Article  PubMed  CAS  Google Scholar 

  13. Leung BP, Sattar N, Crilly A, Prach M, McCarey DW, Payne H, Madhok R, Campbell C, Gracie JA, Liew FY, McInnes IB (2003) A novel anti-inflammatory role for simvastatin in inflammatory arthritis. J Immunol 170:1524–1530

    PubMed  CAS  Google Scholar 

  14. Brackertz D, Mitchell GF, Mackay IR (1977) Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice. Arthritis Rheum 20:841–850

    CAS  Google Scholar 

  15. Wood FD, Pearson CM, Tanaka A (1969) Capacity of mycobacterial Wax D and its subfractions to induce adjuvant arthritis in rats. Int Arch Allergy 35:456–467

    PubMed  CAS  Google Scholar 

  16. Palmer G, Chobaz V, Talabot-Ayer D, Taylor S, So A, Gabay C, Busso N (2004) Assessment of the efficacy of differernt statins in murine collagen-induced arthritis. Arthritis Rheum 50:4051–4059

    Article  PubMed  CAS  Google Scholar 

  17. John S, Jacobi J, Delles C, Schlaich MP, Schneider M, Schmieder RE (2000) Rapid improvement of endothelial function after lipid-lowering therapy with cerivastatin within two weeks. J Am Cardiol 35:256A

    Google Scholar 

  18. Kurakata S, Kada M, Shimada Y, Komai T, Nomoto K (1996) Effects of different inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, pravastatin sodium and simvastatin, on sterol synthesis and immunological functions in human lymphocytes in vitro. Immunopharmacol 34:51–61

    Article  CAS  Google Scholar 

  19. Lu B, Rutledge BJ, Gu L, Fiorillo J, Lukacs NW, Kunkel SL, North R, Gerard C, Rollins BJ (1998) Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med 187:601–608

    Article  PubMed  CAS  Google Scholar 

  20. Chinetti G, Fruchart JC, Staels B (2000) Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation. Inflamm Res 49:497–505

    Article  PubMed  CAS  Google Scholar 

  21. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature 391:79–82

    Article  PubMed  CAS  Google Scholar 

  22. Devchand PR, Keller H, Peters JM, Vazquez M, Gonzalez FJ, Wahli W (1996) The PPARα-leukotriene B4 pathway to inflammation control. Nature 384:39–43

    Article  PubMed  CAS  Google Scholar 

  23. Nezasa K, Higaki K, Matsumura T, Inazawa K, Hasegawa H, Nakano M, Koike M (2002) Liver-specific distribution of rosuvastatin in rats: comparison with pravastain and simvastatin. Drug Metab Dispos 30:1158–1163

    Article  PubMed  CAS  Google Scholar 

  24. Yamzaki M, Suzuki H, Hanano M, Tokui T, Komai T, Sugiyama Y (1993) Na+-independent multispecific anion transporter mediates active transport of pravastatin into rat liver. Am Physiol Soc 264:G36–G44

    Google Scholar 

  25. Yada T, Nakata M, Shiraishi T, Kakei M (1999) Inhibition by simvastatin, but not pravastatin, of glucose-induced cytosolic Ca2+ signaling and insulin secretion due to blockade of L-type Ca2+ channels in rat islet β-cells. Br J Pharmacol 126:1205–1213

    Article  PubMed  CAS  Google Scholar 

  26. Kanda M, Satoh K, Ichihara K (2003) Effects of atorvastatin and pravastatin on glucose tolerance in diabetic rats mildly induced by streptozotocin. Biol Pharm Bull 26:1681–1684

    Article  PubMed  CAS  Google Scholar 

  27. Chamberlian LH (2001) Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. FEBS Lett 507:357–361

    Article  Google Scholar 

  28. Sever PS, Dahlf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O’Brian E, Östergren J (2003) Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT–LLA): a multicentre randomised controlled trial. Lancet 361:1149–1158

    Article  PubMed  CAS  Google Scholar 

  29. Jackson G (1997) Drug points: simvastatin and impotence. BMJ 315:31

    Google Scholar 

  30. Halkin A, Lossos IS, Mevorach D (1996) HMG-CoA reductase inhibitor-induced impotence. Ann Pharmacother 30:192

    PubMed  CAS  Google Scholar 

  31. Hyyppa MT, Kronholm E, Virtanen A, Leino A, Jula A (2003) Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology 28:181–194

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

We express our gratitude to K. Niki, K. Furukawa and E. Honda for their helpful discussion and technical assistance. And we would like to thank Sankyo Corporation for providing pravastatin.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koji Kinoshita.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yamagata, T., Kinoshita, K., Nozaki, Y. et al. Effects of pravastatin in murine collagen-induced arthritis. Rheumatol Int 27, 631–639 (2007). https://doi.org/10.1007/s00296-006-0270-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-006-0270-9

Keywords

Navigation